ALMS vs ARQT Stock Comparison
ARQT currently leads ALMS in this stock comparison, with AIQ scores of 69 vs 20. The clearest difference is momentum.
What is the main difference between ALMS and ARQT?
ARQT leads the current stock comparison as Arcutis Biotherapeutics, Inc., with the clearest separation coming from momentum and the broader AIQ evidence mix.
AlgovestIQ AIQ Comparison
Alumis Inc. vs Arcutis Biotherapeutics, Inc.
ARQT leads
ARQT leads by 49 AIQ points, primarily on Momentum and Quality, and the lead has widened from 42 points over 30 sessions. Wall Street currently favors ALMS on target upside.
Stable: 4 of 5 evidence groups support ARQT, its lead is widening, and its current signal state is conflicted.
Alumis Inc.
Arcutis Biotherapeutics, Inc.
The Algovestiq AIQ Score currently favors ARQT over ALMS, 69 versus 20 as of Nov 15, 2026. ARQT's advantage is driven primarily by stronger momentum and quality. ARQT also shows the stronger technical structure relative to its 50-day moving average, though analyst target upside currently favors ALMS. 4 of 5 covered evidence groups favor ARQT today, and the comparison is rated Stable on stability: the leader is throwing conflicting signals. ARQT lead: Strengthening — the AIQ differential moved from 42 to 49 points over 30 sessions.
Compare Alumis Inc. and Arcutis Biotherapeutics, Inc. across the Algovestiq AIQ Score, valuation, quality, momentum, risk, technicals and analyst expectations.
Performance over time
Price return from daily closes; distributions are not included.
Price return comparison
Growth of $10,000, price only
Split-adjusted closes only. Distributions are excluded, which understates the return of any fund or stock that pays them.
Compare ALMS and ARQT against another ticker
Open a multi-ticker workspace without changing this focused pair page.
AIQ Factor Divergence
Where the two separate, on the four dimensions behind the AIQ Score. Bars read outward from a shared zero: further from the centre is a wider gap.
- Momentum13 vs 76ARQT +63
- Quality29 vs 76ARQT +47
- Risk Resilience20 vs 46ARQT +26
4 of 5 evidence groups favor ARQT. ARQT’s edge is concentrated in momentum and quality.
What changed since the last close
Latest scored session 2026-11-13, compared against the prior scored session 2026-11-12.
Largest factor move: Quality -2
New signals
- BB Lower Band Breach — bullish, volatility, short horizon
Largest factor move: Momentum -2
New signals
- ADX Trend Weakening — neutral, trend, medium horizon
- OBV Bullish Divergence — bullish, volume, medium horizon (-1.9%)
- Price Reclaimed 50-Day MA — bullish, trend, medium horizon
ARQT's lead was unchanged in the latest session.
Deeper signal detail for each name lives on its own signals page — ALMS and ARQT both carry a full feed there.
The central trade-off
ARQT (Arcutis Biotherapeutics, Inc.): the stronger current systematic profile, led by momentum and quality.
ALMS (Alumis Inc.): the counter-case, on analyst expectations.
The AIQ Score and Wall Street therefore point in different directions on this pair.
Which one fits your objective
The same two names rank differently depending on what you are optimizing for. All six reads are shown at once — none of them is hidden behind a toggle.
Balanced
ARQTARQT on the overall AIQ Score, which weights Quality and Value most heavily.
Growth
ALMSALMS on combined revenue and EPS growth.
Value
EvenThe two are level on Value.
Momentum
ARQTARQT on the Momentum factor, by 63 points.
Lower downside
ARQTARQT on Risk Resilience, by 26 points.
Analyst upside
ALMSALMS on implied upside to the consensus price target.
AIQ vs Wall Street
The model and the Street disagree here: AIQ favors ARQT, analyst targets favor ALMS. That disagreement is the most useful thing on this page.
| Measure | ALMS | ARQT | Note |
|---|---|---|---|
| Implied upside to target | +375% | +51.3% | ALMS has more room |
| Target dispersion | +82.7% | +21.1% | Lower is tighter analyst agreement |
| Consensus | Buy | Buy | Context, not a primary driver |
| Analysts covering | 10 | 8 | Higher coverage generally improves confidence |
The two are measuring different things. The AIQ Score reads current fundamentals, valuation, trend and risk; analyst targets price forward expectations. A divergence of this kind is either a contrarian opportunity or a sign the model is missing something already priced in — it is worth resolving before acting on either.
Analyst targets are expectations, not predictions. Dispersion matters as much as the midpoint.
AIQ Agreement Matrix
4 of 5 covered evidence groups favor ARQT. A wide gap backed by one group is a weaker case than a narrow gap backed by five.
| Evidence group | Favors | Reading |
|---|---|---|
| AIQ Score | ARQT | 20 vs 69 |
| Fundamentals | ARQTon balance | revenue growth 14.7% vs 10.8%; EPS growth 34.2% vs -36.4%; TTM ROE -25.1% vs 3.6%; gross margin -13.1% vs 91.2%; operating margin -61.2% vs 6.9% — ARQT takes 3 of 5 decided legs, not all of them |
| Valuation | Not covered | Not covered |
| Technicals | ARQT | Price vs 50-day -22.7% vs 2.6%; vs 200-day -72.6% vs 11.4% |
| Risk Resilience | ARQT | Risk Resilience 20 vs 46 |
| Analyst expectations | ALMS | Target upside 375% vs 51.3% |
✓ agrees with the overall verdict · ✕ points the other way. Groups marked “not covered” lack data on one or both of ALMS and ARQT and are excluded from the count.
AIQ Decision Stability
The conclusion rests on a wide gap and broad agreement. It is unlikely to turn on a single session.
- The AIQ gap is wide at 49 points. (supports the conclusion holding)
- 4 of 5 covered evidence groups point the same way. (supports the conclusion holding)
- The leader's advantage has been widening. (supports the conclusion holding)
- The lead has been steady session to session. (supports the conclusion holding)
- The leader is throwing conflicting signals. (argues the conclusion is provisional)
Stability combines the score gap, how broadly the evidence agrees, how steady the lead has been across daily snapshots, the current signal state on both names, and analyst dispersion on ARQT.
How the comparison changed
120 daily snapshots · May 27 – Nov 13ARQT lead: Strengthening — the AIQ differential moved from 42 to 49 points over 30 sessions.
- Today
- ARQT +49
- 20 vs 69
- 7 sessions ago
- ARQT +50
- 21 vs 71
- 30 sessions ago
- ARQT +42
- 22 vs 64
- 90 sessions ago
- ARQT +17
- 46 vs 63
The lead has not changed hands in this window.
AIQ Signal Divergence
Only the signals that bear on the head-to-head. A conflicted name is carrying bullish and bearish rules at the same time — the technical evidence is not pointing one way.
1 bullish / 3 bearish / 1 neutral, conflicted
Only ALMS
- Death Cross Active — bearish, trend, long horizon (182.17%)
- BB Lower Band Breach — bullish, volatility, short horizon
- Downtrend Structure Active — bearish, trend, long horizon
4 bullish / 1 bearish / 2 neutral, conflicted
Only ARQT
- Golden Cross Active — bullish, trend, long horizon (8.51%)
- ADX Trend Weakening — neutral, trend, medium horizon
- OBV Bullish Divergence — bullish, volume, medium horizon (-1.9%)
- Price Reclaimed 50-Day MA — bullish, trend, medium horizon
- Uptrend Structure Active — bullish, trend, long horizon
Both carry 2 more signals that do not separate them: ATR Expansion - Breakout Mode, Beta Spike Warning.
ARQT leads the comparison while carrying a conflicted signal state, which is one reason the stability rating is not higher.
Price vs model alignment
Whether the latest session's price move confirms what the model did over the same session, or contradicts it.
Price and the AIQ Score both moved down over the latest session (price -8.65%, AIQ -1 points).
Price is up while the AIQ Score moved down 1 points over the same session — price and model disagree (price +2.65%, AIQ -1 points).
What would flip this result
A state, not a forecast. These are the specific, observable changes that would reverse the verdict — not a price prediction.
- 1ALMS closes the Momentum gap — currently 63 points behind, the largest single contributor to ARQT's edge.
- 2ALMS's Death Cross Active resolves — a bearish trend rule currently active against it.
- 3ARQT's conflicting signal state resolves bearish — it currently carries 4 bullish and 1 bearish rules at once.
- 4A market regime shift would change the factor readings behind both scores; a rotation toward or away from quality, value or momentum could move the result.
The full evidence
Every number behind the verdict. The leader is called above each group so you are not left to solve it from the table.
Fundamentals
ARQT leads on balance| Metric | ALMS | ARQT |
|---|---|---|
| Revenue growth (YoY) | 14.7% | 10.8% |
| EPS growth (YoY) | 34.2% | -36.4% |
| Gross margin | -13.1% | 91.2% |
| Operating margin | -61.2% | 6.9% |
| Return on equity (TTM) | -25.1% | 3.6% |
| Debt to equity | 0.09 | 0.47 |
Performance
ARQT leads 6 of 6 windows| Metric | ALMS | ARQT |
|---|---|---|
| 1 week (5 sessions) | -7.1% | 10.6% |
| 1 month (20 sessions) | -8.5% | -1.9% |
| 3 months (63 sessions) | -78% | 10.3% |
| 6 months (126 sessions) | -75.5% | 32.6% |
| Year to date | -42.6% | -2.7% |
| 1 year (252 sessions) | 6.9% | 20.5% |
Technicals
ARQT has the stronger structure| Metric | ALMS | ARQT |
|---|---|---|
| RSI (14) | 34 | 48.3 |
| ADX (14) | 40.5 | 24.5 |
| Price vs 50-day | -22.7% | 2.6% |
| Price vs 200-day | -72.6% | 11.4% |
| Volatility (1M, annualized) | 82.5% | 97.4% |
Risk
ARQT is the more resilient| Metric | ALMS | ARQT |
|---|---|---|
| Beta | 1.98 | 1.47 |
| Sharpe ratio | 0.65 | 0.59 |
| Sortino ratio | 1.17 | 0.85 |
| Max drawdown | -81.5% | -37.5% |
| Current drawdown | -81.5% | -17% |
| Annualized volatility | 137.6% | 56.5% |
| Value at risk (95%) | -7.4% | -4.5% |
Straight answers
Each answer is regenerated from the current snapshot, not written once and left to age.
Which is better, ALMS or ARQT?
On the Algovestiq AIQ Score, ARQT is the stronger of the two as of Nov 15, 2026, scoring 69 against ALMS's 20. The edge comes from momentum and quality. This is a systematic score, not a recommendation: it ranks the two on the same evidence, it does not know your holding period or tax position.
Is ALMS or ARQT the better buy right now?
ARQT carries the stronger systematic profile as of Nov 15, 2026, and the comparison is rated Stable — 4 of 5 covered evidence groups agree. A Stable rating means the gap is wide and the evidence is broad, so the conclusion is unlikely to turn on a single session.
Why does the AIQ Score favor ARQT over ALMS?
The composite weights Quality, Value, Momentum and Risk Resilience. ARQT leads Momentum by 63 points; ARQT leads Quality by 47 points; ARQT leads Risk Resilience by 26 points. Where the two split, the factor with the larger weight carries the result.
Which has more analyst upside, ALMS or ARQT?
Analyst price targets imply +375% upside for ALMS and +51.3% for ARQT, so the Street currently favors ALMS. That points the opposite way to the AIQ Score, which favors ARQT. The two are measuring different things: the model reads current fundamentals, valuation, trend and risk; the Street is pricing forward expectations. A divergence of this kind is either a contrarian opportunity or a sign the model is missing something the analysts have already priced — it is the single most useful row on this page to investigate. Analyst targets are expectations, not predictions, and dispersion matters as much as the midpoint.
Which is better value, ALMS or ARQT?
Neither name separates on the peer-relative Value factor. The two are level on Value. The Value factor reads valuation relative to sector peers and to the company's own fundamental quality, so it is not the same as simply having the lower multiple.
Which has stronger growth, ALMS or ARQT?
ALMS on combined revenue and EPS growth. Growth here is measured on reported revenue and earnings, not on forward estimates — it describes what the businesses have delivered, not what the Street expects next.
Which has stronger momentum, ALMS or ARQT?
ARQT on the Momentum factor, by 63 points. Momentum is one of the four weighted factors in the AIQ composite. It has documented persistence over three- to twelve-month horizons, which makes it a timing input rather than a reason to hold something indefinitely.
Which is riskier, ALMS or ARQT?
ARQT is the more resilient of the two, so the other name carries the higher downside risk. ARQT on Risk Resilience, by 26 points. Risk Resilience is a weighted factor in the composite; position sizing usually responds to it more usefully than the buy/avoid decision does.
Is ALMS more profitable than ARQT?
ARQT leads on the comparable margin measures — gross margin -13.1% vs 91.2%; operating margin -61.2% vs 6.9%; ttm roe -25.1% vs 3.6%.
Is ARQT's lead over ALMS getting stronger or weaker?
ARQT lead: Strengthening — the AIQ differential moved from 42 to 49 points over 30 sessions. This is measured from 120 daily comparison snapshots between 2026-05-27 and 2026-11-13. The lead has not changed hands in that window.
What would change the ALMS vs ARQT verdict?
The result is a state, not a forecast, so it changes when the underlying evidence changes. Concretely: ALMS closes the Momentum gap — currently 63 points behind, the largest single contributor to ARQT's edge; ALMS's Death Cross Active resolves — a bearish trend rule currently active against it; ARQT's conflicting signal state resolves bearish — it currently carries 4 bullish and 1 bearish rules at once; a market regime shift would change the factor readings behind both scores; a rotation toward or away from quality, value or momentum could move the result.
What do the current signals say about ALMS and ARQT?
ALMS: 1 bullish / 3 bearish / 1 neutral, conflicted. ARQT: 4 bullish / 1 bearish / 2 neutral, conflicted. A conflicted state means bullish and bearish rules are active on the same name at once — the technical evidence is not pointing one way, and a decision taken on it carries more timing risk. The most decision-relevant rule on ALMS is Death Cross Active (bearish, long horizon). On ARQT it is Golden Cross Active (bullish, long horizon).
Compare ALMS and ARQT with others
Continue your research
This page answers which of the two. These answer the questions on either side of it.
How this comparison is scored
The Algovestiq AIQ Score composites four factors — Quality, Value, Momentum and Risk, each carrying a fixed weight. Sentiment is reported separately as SentimentPulse and is not folded into the composite. Scores refresh every trading day, and this page regenerates from the latest snapshot rather than being written once.
The verdict names a leader, states how broadly six independent evidence groups agree, and rates how durable that conclusion is given the score gap, its recent trajectory and the current signal state on both names.
How to use side-by-side comparison →This comparison is informational and educational, not investment advice. AIQ scores update daily; re-check after earnings, guidance or macro data that materially changes either name’s factor profile.